133 related articles for article (PubMed ID: 23773927)
1. Influence of pre-analytical conditions on the measurement of components of the GH/IGF axis in rats.
Bielohuby M; Popp S; Bidlingmaier M
Growth Horm IGF Res; 2013 Oct; 23(5):141-8. PubMed ID: 23773927
[TBL] [Abstract][Full Text] [Related]
2. Effects of milk replacer composition on selected blood metabolites and hormones in preweaned Holstein heifers.
Daniels KM; Hill SR; Knowlton KF; James RE; McGilliard ML; Akers RM
J Dairy Sci; 2008 Jul; 91(7):2628-40. PubMed ID: 18565922
[TBL] [Abstract][Full Text] [Related]
3. Instability of IGF-IGFBP complex as a cause of the different performance of serum and EDTA-plasma after storage: EDTA-plasma is preferable for evaluating bioactive IGF especially in the mouse.
Setoyama T; Miyamoto S; Nikaido M; Muto M; Chiba T
Growth Horm IGF Res; 2015 Oct; 25(5):227-31. PubMed ID: 26144570
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the IGF system in 15 patients with Alström syndrome.
Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
[TBL] [Abstract][Full Text] [Related]
6. Exercise-induced insulin-like growth factor I system concentrations after training in women.
Gregory SM; Spiering BA; Alemany JA; Tuckow AP; Rarick KR; Staab JS; Hatfield DL; Kraemer WJ; Maresh CM; Nindl BC
Med Sci Sports Exerc; 2013 Mar; 45(3):420-8. PubMed ID: 23034644
[TBL] [Abstract][Full Text] [Related]
7. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A
Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
9. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
10. Coordinated regulation of the GH/IGF system genes during refeeding in rainbow trout (Oncorhynchus mykiss).
Gabillard JC; Kamangar BB; Montserrat N
J Endocrinol; 2006 Oct; 191(1):15-24. PubMed ID: 17065385
[TBL] [Abstract][Full Text] [Related]
11. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
12. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
[TBL] [Abstract][Full Text] [Related]
13. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
14. Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients.
Laursen T; Møller J; Fisker S; Jorgensen JO; Christiansen JS
Growth Horm IGF Res; 1999 Dec; 9(6):451-7. PubMed ID: 10629166
[TBL] [Abstract][Full Text] [Related]
15. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
[TBL] [Abstract][Full Text] [Related]
16. The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects.
Kanaley JA; Frystyk J; Møller N; Dall R; Chen JW; Nielsen SC; Christiansen JS; Jørgensen JO; Flyvbjerg A
Growth Horm IGF Res; 2005 Aug; 15(4):283-90. PubMed ID: 16027018
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone administration to mature miniature Brahman cattle treated with or without insulin on circulating concentrations of insulin-like growth factor-I and other metabolic hormones and metabolites.
Chase CC; Elsasser TH; Spicer LJ; Riley DG; Lucy MC; Hammond AC; Olson TA; Coleman SW
Domest Anim Endocrinol; 2011 Jul; 41(1):1-13. PubMed ID: 21420268
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy.
Monaghan JM; Godber IM; Lawson N; Kaur M; Wark G; Teale D; Hosking DJ
Ann Clin Biochem; 2004 May; 41(Pt 3):220-6. PubMed ID: 15117436
[TBL] [Abstract][Full Text] [Related]
20. Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH.
Kicman AT; Miell JP; Teale JD; Powrie J; Wood PJ; Laidler P; Milligan PJ; Cowan DA
Clin Endocrinol (Oxf); 1997 Jul; 47(1):43-50. PubMed ID: 9302371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
